Imunon, Inc. (IMNN) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Next earnings call: 2026-08-11 (Q2 2026) — full calendar

Earnings Reports

Immunon (IMNN) Q2 2026: Phase 3 Enrollment Surges 67% Above Plan, Reinforcing Clinical Momentum
August 11, 2026

Browse all companies